Cite
HARVARD Citation
Zeitoun, J. et al. (2018). Post‐marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross‐sectional study. International journal of cancer. 142 (2), pp. 414-423. [Online].